2022
DOI: 10.3390/biom12020310
|View full text |Cite
|
Sign up to set email alerts
|

Discovering the Triad between Nav1.5, Breast Cancer, and the Immune System: A Fundamental Review and Future Perspectives

Abstract: Nav1.5 is one of the nine voltage-gated sodium channel-alpha subunit (VGSC-α) family members. The Nav1.5 channel typically carries an inward sodium ion current that depolarises the membrane potential during the upstroke of the cardiac action potential. The neonatal isoform of Nav1.5, nNav1.5, is produced via VGSC-α alternative splicing. nNav1.5 is known to potentiate breast cancer metastasis. Despite their well-known biological functions, the immunological perspectives of these channels are poorly explored. Th… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2023
2023
2024
2024

Publication Types

Select...
3

Relationship

0
3

Authors

Journals

citations
Cited by 3 publications
(1 citation statement)
references
References 176 publications
0
1
0
Order By: Relevance
“…VGSCs are present in excitable and non-excitable cells, including microglia, astrocytes, immune cells, fibroblasts, and cancer cells, and play various biological roles, such as tumour cell migration and immune cell phagocytosis ( Black and Waxman, 2013 ; Roger et al, 2015 ). Nav1.5, encoded by SCN5A, is an essential receptor in breast cancer growth and migration ( Rajaratinam et al, 2022 ). Notably, inhibition of Nav1.5 function or expression can inhibit breast cancer cell migration in vivo and in vitro ( Brackenbury et al, 2007 ; Nelson et al, 2015 ).…”
Section: Introductionmentioning
confidence: 99%
“…VGSCs are present in excitable and non-excitable cells, including microglia, astrocytes, immune cells, fibroblasts, and cancer cells, and play various biological roles, such as tumour cell migration and immune cell phagocytosis ( Black and Waxman, 2013 ; Roger et al, 2015 ). Nav1.5, encoded by SCN5A, is an essential receptor in breast cancer growth and migration ( Rajaratinam et al, 2022 ). Notably, inhibition of Nav1.5 function or expression can inhibit breast cancer cell migration in vivo and in vitro ( Brackenbury et al, 2007 ; Nelson et al, 2015 ).…”
Section: Introductionmentioning
confidence: 99%